{"id":"W4367362646","doi":"10.1111/j.1742-1241.2003.tb10544.x","title":"XELODA® AND TAXOTERE®: A REVIEW OF THE DEVELOPMENT OF THE COMBINATION FOR USE IN METASTATIC BREAST CANCER","year":2003,"lang":"en","type":"review","venue":"International Journal of Clinical Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Anthracycline; Adverse effect; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007612765,0.000892497,0.00193078,0.003703426,0.0003030384,0.0008117816,0.001058451,0.0008676589,0.003498731],"category_scores_gemma":[0.0006846074,0.0004244322,0.000598259,0.003748885,0.0004420379,0.001277157,0.0004338676,0.001281647,0.001801446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004312953,"about_ca_system_score_gemma":0.0007632861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001249616,"about_ca_topic_score_gemma":0.002707208,"domain_scores_codex":[0.9997438,0.00004630813,0.00004990741,0.00004448834,0.0001007421,0.0000148515],"domain_scores_gemma":[0.9996384,0.0001733198,0.0000612166,0.00001081697,0.00008375836,0.00003233734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001340027,0.0001471252,0.000199236,0.02447141,0.0001511976,0.0004546783,0.00007225099,0.0004679589,0.001714416,0.001464509,0.01838598,0.9523372],"study_design_scores_gemma":[0.00008892347,0.0003582933,0.001784297,0.005995979,0.0002488482,0.004111017,0.00008039452,0.0002105602,0.0007983982,0.001349587,0.984945,0.00002858338],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001992901,0.9988402,0.0001147141,0.0001019312,0.0000839159,0.000008063616,0.00001513206,0.000006214392,0.0006306556],"genre_scores_gemma":[0.0007043569,0.9985664,0.0002424019,0.00008400547,0.00006735265,0.000007355438,0.0000235897,0.00000125663,0.0003033225],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003703426,"threshold_uncertainty_score":0.01170444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3272185162981635,"score_gpt":0.5989358573477391,"score_spread":0.2717173410495757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}